[HTML][HTML] Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

BD Keith - BMC cancer, 2008 - Springer
Background Glucocorticoids are often used in the treatment of nonhematologic malignancy.
This review summarizes the clinical evidence of the effect of glucocorticoid therapy on …

Glucocorticoids as an adjunct to oncologic treatment in solid malignancies–not an innocent bystander

C Maurice-Dror, R Perets, G Bar-Sela - Critical reviews in oncology …, 2018 - Elsevier
Glucocorticoids are steroidal hormones which exert their action via genomic and non-
genomic mechanisms. In the clinical setting, glucocorticoids are utilized for their anti …

Role of glucocorticoids in breast cancer

JS Vaidya, G Baldassarre, MA Thorat… - Current …, 2010 - ingentaconnect.com
Glucocorticoids play an essential role in embryonic development and tissue homeostasis
and possess important antiinflammatory and immunosuppressive properties. Due to their …

[HTML][HTML] The role of glucocorticoids in breast cancer therapy

IB Mitre-Aguilar, D Moreno-Mitre, J Melendez-Zajgla… - Current …, 2022 - mdpi.com
Glucocorticoids (GCs) are anti-inflammatory and immunosuppressive steroid molecules
secreted by the adrenal gland and regulated by the hypothalamic–pituitary–adrenal (HPA) …

[PDF][PDF] Glucocorticoids in clinical oncology

D Walsh, J Avashia - Cleveland Clinic journal of medicine, 1992 - academia.edu
DECLAN WALSH, MSc., AND JAY AVASHIA, MD n Glucocorticoids have been used in
clinical oncology for more than three decades. Their anti-inflammatory action plays a major …

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

M Fakih, CS Johnson, DL Trump - Urology, 2002 - goldjournal.net
Glucocorticoids have been used for a substan-tial period to treat patients with advanced
androgen-independent prostate cancer (AIPC). Although known for their anti-inflammatory …

Glucocorticoids and cancer

MA Pufall - Glucocorticoid Signaling: From Molecules to Mice to …, 2015 - Springer
Unlike other steroid hormone receptors, the glucocorticoid receptor (GR) is not considered
an oncogene. In breast cancer, the estrogen receptor (ER) drives cell growth, proliferation …

Glucocorticoids augment survival and proliferation of tumor cells

S Guendisch, E Boeckeler, U Behrends… - Anticancer …, 2012 - ar.iiarjournals.org
Background: Glucocorticoids are widely used for cancer patients, although they can reduce
the efficacy of anticancer treatment. Materials and Methods: We characterized non-apoptotic …

Side effects of corticosteroids in patients with advanced cancer: a systematic review

Y Hatano, H Matsuoka, L Lam, DC Currow - Supportive Care in Cancer, 2018 - Springer
Purpose Corticosteroids are commonly used in palliative care settings, but are associated
with several side effects. Although adverse events (AEs) are highly distressing for patients …

[HTML][HTML] Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women

M Cairat, M Al Rahmoun, MJ Gunter, PE Heudel… - BMC medicine, 2021 - Springer
Background Glucocorticoids could theoretically decrease breast cancer risk through their
anti-inflammatory effects or increase risk through immunosuppression. However …